Pulmonary Hypertension: Classification and Pathogenesis
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Other Pulmonary Disorders
Rous Sarcoma Virus (RSV) and Cancer
Chronic Obstructive Pulmonary Disease
Pulmonary Tuberculosis II
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 26, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Carlos A Pagan1, Catherine A Shu2, John P Crapanzano1
1Department of Pathology and Cell Biology, Columbia University Irving Medical Center/NewYork-Presbyterian Hospital, New York, NY.
Molecular testing (MT) shows discordance with histology in synchronous pulmonary carcinomas. Comprehensive molecular review (CMR) using next-generation sequencing (NGS) is crucial for assessing related mutations.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: